Computational study of missense mutations in phenylalanine hydroxylase

Journal of Molecular Modeling

Volumn 21, Issue 4, 2015, Pages 1-10

  Réblová, Kamila ^a   Kulhánek, Petr ^a   Fajkusová, Lenka ^a  

^a MASARYK UNIVERSITY   (Czech Republic)

Author keywords

Computer simulation; Genetic disease; Hyperphenylalaninemia; In silico tool; Missense mutation

Indexed keywords

PHENYLALANINE 4 MONOOXYGENASE; SODIUM CHLORIDE; TETRAMER;

AMINO ACID SEQUENCE; ARTICLE; COMPUTER MODEL; COMPUTER PROGRAM; DATA BASE; GENOTYPE; HOMOZYGOSITY; HOMOZYGOTE; HUMAN; HYPERPHENYLALANINEMIA; IONIC STRENGTH; MAJOR CLINICAL STUDY; MISSENSE MUTATION; MOLECULAR DYNAMICS; MUTANT; PHENOTYPE; PHENYLKETONURIA; POLYPHEN 2; PRIORITY JOURNAL; SIFT; SNPS3D; STRUCTURAL BIOINFORMATICS; CHEMISTRY; COMPUTER SIMULATION; GENETICS; PATHOLOGY; PROTEIN CONFORMATION; STRUCTURE ACTIVITY RELATION;

COMPUTER SIMULATION; GENOTYPE; HUMANS; MOLECULAR DYNAMICS SIMULATION; MUTATION, MISSENSE; PHENOTYPE; PHENYLALANINE HYDROXYLASE; PHENYLKETONURIAS; PROTEIN CONFORMATION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84924407765     PISSN: 16102940     EISSN: 09485023     Source Type: Journal    
DOI: 10.1007/s00894-015-2620-6     Document Type: Article

References (58)

1. Kaufman S (1987) Enzymology of the phenylalanine-hydroxylating system. Enzyme 38:286–295
2. Stenson PD, Mort M, Ball EV, Shaw K, Phillips AD, Cooper DN (2014) The Human Gene Mutation Database: building a comprehensive mutation repository for clinical and molecular genetics, diagnostic testing and personalized genomic medicine. Hum Genet 133:1–9
3. Gjetting T, Petersen M, Guldberg P, Guttler F (2001) In vitro expression of 34 naturally occurring mutant variants of phenylalanine hydroxylase: Correlation with metabolic phenotypes and susceptibility toward protein aggregation. Mol Genet Metab 72:132–143
4. Pey AL, Desviat LR, Gamez A, Ugarte M, Perez B (2003) Phenylketonuria: genotype-phenotype correlations based on expression analysis of structural and functional mutations in PAH. Hum Mutat 21:370–378
5. Gersting SW, Kemter KF, Staudigl M, Messing DD, Danecka MK, Lagler FB, Sommerhoff CP, Roscher AA, Muntau AC (2008) Loss of function in phenylketonuria is caused by impaired molecular motions and conformational instability. Am J Hum Genet 83:5–17
6. Gregersen N, Bross P, Andresen BS, Pedersen CB, Corydon TJ, Bolund L (2001) The role of chaperone-assisted folding and quality control in inborn errors of metabolism: protein folding disorders. J Inherit Metab Dis 24:189–212
7. Guldberg P, Rey F, Zschocke J, Romano V, Francois B, Michiels L, Ullrich K, Hoffmann GF, Burgard P, Schmidt H, Meli C, Riva E, Dianzani I, Ponzone A, Rey J, Guttler F (1998) A European multicenter study of phenylalanine hydroxylase deficiency: classification of 105 mutations and a general system for genotype-based prediction of metabolic phenotype. Am J Hum Genet 63:71–79
8. Desviat LR, Perez B, Gamez A, Sanchez A, Garcia MJ, Martinez-Pardo M, Marchante C, Boveda D, Baldellou A, Arena J, Sanjurjo P, Fernandez A, Cabello ML, Ugarte M (1999) Genetic and phenotypic aspects of phenylalanine hydroxylase deficiency in Spain: molecular survey by regions. Eur J Hum Genet 7:386–392
9. Desviat LR, Perez B, Garcia MJ, MartinezPardo M, Baldellou A, Arena J, Sanjurjo P, Campistol J, Couce ML, Fernandez A, Cardesa J, Ugarte M (1997) Relationship between mutation genotype and biochemical phenotype in a heterogeneous Spanish phenylketonuria population Eur. J Hum Genet 5:196–202
10. Zhu TW, Ye J, Han LS, Qiu WJ, Zhang HW, Liang LL, Gu XF (2013) Variations in genotype-phenotype correlations in phenylalanine hydroxylase deficiency in Chinese Han population. Gene 529:80–87
11. Trunzo R, Santacroce R, D’Andrea G, Longo V, De Girolamo G, Dimatteo C, Leccese A, Lillo V, Papadia F, Margaglione M (2013) Mutation analysis in hyperphenylalaninemia patients from South Italy. Clin Biochem 46:1896–1898
12. Song F, Qu YJ, Zhang T, Jin YW, Wang H, Zheng XY (2005) Phenylketonuria mutations in Northern China. Mol Genet Metab 86:S107–S118
13. Blau N, Belanger-Quintana A, Demirkol M, Feillet F, Giovannini M, MacDonald A, Trefz FK, van Spronsen F, Centers EP (2010) Management of phenylketonuria in Europe: survey results from 19 countries. Mol Genet Metab 99:109–115
14. Leandro J, Nascimento C, de Almeida IT, Leandro P (2006) Co-expression of different subunits of human phenylalanine hydroxylase: evidence of negative interallelic complementation. Biochim Biophys Acta 1762:544–550
15. Leandro J, Leandro P, Flatmark T (2011) Heterotetrameric forms of human phenylalanine hydroxylase: Co-expression of wild-type and mutant forms in a bicistronic system. Biochim Biophys Acta 1812:602–612
16. Thony B, Auerbach G, Blau N (2000) Tetrahydrobiopterin biosynthesis, regeneration and functions. Biochem J 347:1–16
17. Pontoglio M, Barra J, Hadchouel M, Doyen A, Kress C, Bach JP, Babinet C, Yaniv M (1996) Hepatocyte nuclear factor 1 inactivation results in hepatic dysfunction, phenylketonuria, and renal Fanconi syndrome. Cell 84:575–585
18. Thony B, Neuheiser F, Kierat L, Blaskovics M, Arn PH, Ferreira P, Rebrin I, Ayling J, Blau N (1998) Hyperphenylalaninemia with high levels of 7-biopterin is associated with mutations in the PCBD gene encoding the bifunctional protein pterin-4a-carbinolamine dehydratase and transcriptional coactivator (DCoH). Am J Hum Genet 62:1302–1311
19. Citron BA, Davis MD, Milstien S, Gutierrez J, Mendel DB, Crabtree GR, Kaufman S (1992) Identity of 4a-carbinolamine dehydratase, a component of the phenylalanine hydroxylation system, and Dcoh, a transregulator of homeodomain proteins. Proc Natl Acad Sci USA 89:11891–11894
20. Erlandsen H, Stevens RC (1999) The structural basis of phenylketonuria. Mol Genet Metab 68:103–125
21. Erlandsen H, Fusetti F, Martinez A, Hough E, Flatmark T, Stevens RC (1997) Crystal structure of the catalytic domain of human phenylalanine hydroxylase reveals the structural basis for phenylketonuria. Nat Struct Biol 4:995–1000
22. Fusetti F, Erlandsen H, Flatmark T, Stevens RC (1998) Structure of tetrameric human phenylalanine hydroxylase and its implications for phenylketonuria. J Biol Chem 273:16962–16967
23. Kobe B, Jennings IG, House CM, Michell BJ, Goodwill KE, Santarsiero BD, Stevens RC, Cotton RG, Kemp BE (1999) Structural basis of autoregulation of phenylalanine hydroxylase. Nat Struct Biol 6:442–448
24. Pey AL, Stricher F, Serrano L, Martinez A (2007) Predicted effects of missense mutations on native-state stability account for phenotypic outcome in phenylketonuria, a paradigm of misfolding diseases. Am J Hum Genet 81:1006–1024
25. Khan S, Vihinen M (2010) Performance of protein stability predictors. Hum Mutat 31:675–684
26. Flück CE, Mullis PE, Pandey AV (2009) Modeling of human P450 oxidoreductase structure by in silico mutagenesis and MD simulation. Mol Cell Endocrinol 313:17–22
27. Thusberg J, Vihinen M (2009) Pathogenic or not? And if so, then how? Studying the effects of missense mutations using bioinformatics method. Hum Mutat 30:703–714
28. Thusberg J, Vihinen M (2006) Bioinformatic analysis of protein structure-function relationships: case study of leukocyte elastase (ELA2) missense mutations. Hum Mutat 27:1230–1243
29. Cozzi R, Nuccitelli A, D’Onofrio M, Necchi F, Rosini R, Zerbini F, Biagini M, Norais N, Beier C, Telford JL, Grandi G, Assfalg M, Zacharias M, Maione D, Rinaudo CD (2012) New insights into the role of the glutamic acid of the E-box motif in group B Streptococcus pilus 2a assembly. Faseb J 26:2008–2018
30. Skalova D, Zidkova J, Vohanka S, Mazanec R, Musova Z, Vondracek P, Mrazova L, Kraus J, Reblova K, Fajkusova L (2013) CLCN1 mutations in Czech patients with myotonia congenita. In silico analysis of novel and known mutations in the human dimeric skeletal muscle chloride channel. PLoS ONE 8:e82549
31. Carluccio C, Fraternali F, Salvatore F, Fornili A, Zagari A (2013) Structural features of the regulatory ACT domain of phenylalanine hydroxylase PLoS ONE 8:
32. Banerjee S, Wu Q, Yu P, Qi M, Li C (2014) In silico analysis of all point mutations on the 2B domain of K5/K14 causing epidermolysis bullosa simplex: a genotype-phenotype correlation. Mol Biosyst 10:2567–2577
33. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, Kondrashov AS, Sunyaev SR (2010) A method and server for predicting damaging missense mutations. Nat Methods 7:248–249
34. Ng PC, Henikoff S (2001) Predicting deleterious amino acid substitutions. Genome Res 11:863–874
35. Yue P, Melamud E, Moult J (2006) SNPs3D: candidate gene and SNP selection for association studies. BMC Bioinforma 7:166
36. Reblova K, Hruba Z, Prochazkova D, Pazdirkova R, Pouchla S, Fajkusova L (2013) Hyperphenylalaninemia in the Czech Republic: Genotype-phenotype correlations and in silico analysis of novel missense mutations. Clin Chim Acta 419:1–10
37. Sali A, Blundell TL (1993) Comparative protein modeling by satisfaction of spatial restraints. J Mol Biol 234:779–815
38. Pearlman DA, Case DA, Caldwell JW, Ross WS, Cheatham TE, Debolt S, Ferguson D, Seibel G, Kollman P (1995) Amber, a package of computer-programs for applying molecular mechanics, normal-mode analysis, molecular-dynamics and free-energy calculations to simulate the structural and energetic properties of molecules. Comput Phys Commun 91:1–41
39. Brocchieri L, Karlin S (1994) Geometry of interplanar residue contacts in protein structures. Proc Natl Acad Sci USA 91:9297–9301
40. Humphrey W, Dalke A, Schulten K (1996) VMD—visual molecular dynamics. J Mol Graph Model 14:33–38
41. Frishman D, Argos P (1995) Knowledge-based protein secondary structure assignment. Proteins 23:566–579
42. Chothia C (1976) The nature of the accessible and buried surfaces in proteins. J Mol Biol 105:1–12
43. Grantham R (1974) Amino acid difference formula to help explain protein evolution. Science 185:862–864
44. Andersen OA, Stokka AJ, Flatmark T, Hough E (2003) 2.0 angstrom resolution crystal structures of the ternary complexes of human phenylalanine hydroxylase catalytic domain with tetrahydrobiopterin and 3-(2-thienyl)-l-alanine or l-norleucine: substrate specificity and molecular motions related to substrate binding. J Mol Biol 333:747–757
45. Case DA, Darden TA, Cheatham I, T.E., Simmerling CL, Wang J, Duke RE, Luo R, Walker RC, Zhang W, Merz KM, Roberts B, Hayik S, Roitberg A, Seabra G, Swails J, Götz AW, Kolossváry I, Wong KF, Paesani F, Vanicek J, Wolf RM, Liu J, Wu X, Brozell SR, Steinbrecher T, Gohlke H, Cai Q, Ye X, Wang J, Hsieh MJ, Cui G, Roe DR, Mathews DH, Seetin MG, Salomon-Ferrer R, Sagui C, Babin V, Luchko T, Gusarov S, Kovalenko A, and Kollman PA, AMBER 12. 2012: University of California, San Francisco.
46. Hornak V, Abel R, Okur A, Strockbine B, Roitberg A, Simmerling C (2006) Comparison of multiple amber force fields and development of improved protein backbone parameters. Proteins 65:712–725
47. Dang LX, Kollman PA (1995) Free energy of association of the K+: 18-crown-6 complex in water: a new molecular dynamics study. J Phys Chem 99:55–58
48. Gresh N, Sponer JE, Spackova N, Leszczynski J, Sponer J (2003) Theoretical study of binding of hydrated Zn(II) and Mg(II) cations to 5′-guanosine monophosphate. Toward polarizable molecular mechanics for DNA and RNA. J Phys Chem B 107:8669–8681
49. Berendsen HJC, Postma JPM, Vangunsteren WF, Dinola A, Haak JR (1984) Molecular-dynamics with coupling to an external bath. J Chem Phys 81:3684–3690
50. Fitzpatrick PF (2012) Allosteric regulation of phenylalanine hydroxylase. Arch Biochem Biophys 519:194–201
51. McLaughlin RN, Poelwijk FJ, Raman A, Gosal WS, Ranganathan R (2012) The spatial architecture of protein function and adaptation. Nature 491:138–U163
52. Molina-Vila MA, Nabau-Moreto N, Tornador C, Sabnis AJ, Rosell R, Estivill X, Bivona TG, Marino-Buslje C (2014) Activating mutations cluster in the “molecular brake” regions of protein kinases and do not associate with conserved or catalytic residues. Hum Mutat 35:318–28
53. Bardelli T, Donati MA, Gasperini S, Ciani F, Belli F, Blau N, Morrone A, Zammarchi E (2002) Two novel genetic lesions and a common BH4-responsive mutation of the PAH gene in Italian patients with hyperphenylalaninemia. Mol Genet Metab 77:260–266
54. Balmer C, Pandey AV, Rufenacht V, Nuoffer JM, Fang P, Wong LJ, Haberle J (2014) Mutations and polymorphisms in the human argininosuccinate lyase (ASL). Gene Hum Mutat 35:27–35
55. Lesueur F, Bouadjar B, Lefevre C, Jobard F, Audebert S, Lakhdar H, Martin L, Tadini G, Karaduman A, Emre S, Saker S, Lathrop M, Fischer J (2007) Novel mutations in ALOX12B in patients with autosomal recessive congenital ichthyosis and evidence for genetic heterogeneity on chromosome 17p13. J Investig Dermatol 127:829–834
56. Yang HQ, Liu L, Shin HD, Li JH, Du GC, Chen J (2013) Structure-guided systems-level engineering of oxidation-prone methionine residues in catalytic domain of an alkaline alpha-amylase from Alkalimonas amylolytica for significant improvement of both oxidative stability and catalytic efficiency. PLoS ONE 8:e57403
57. Lindorff-Larsen K, Piana S, Dror RO, Shaw DE (2011) How fast-folding proteins fold. Science 334:517–520
58. Eldar A, Rozenberg H, Diskin-Posner Y, Rohs R, Shakked Z (2013) Structural studies of p53 inactivation by DNA-contact mutations and its rescue by suppressor mutations via alternative protein-DNA interactions. Nucleic Acids Res 41:8748–8759